Macquarie Group’s Imunon IMNN Stock Holding History

Macquarie Group’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18	Closed	-$9K	–	2253
2017 Q4	$9K	Buy	+18	New	+$10.2K	﹤0.01%	2274

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dillon & Associates Jackson, Michigan $726M AUM 18.59% 1-Year Est. Return

Macquarie Group's IMNN Position: Q1 2018 in Review

Macquarie Group sold out of Imunon (IMNN) in Q1 2018, closing a stake of 18 shares — an estimated $9K sold.

Macquarie Group first reported a position in IMNN in Q4 2017 and held it in 1 quarter. The position peaked at $9K in Q4 2017. 22 funds tracked by Wall St. Rank hold IMNN as of Q1 2018.

Macquarie Group reported no remaining Imunon position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 18 Imunon shares in Q1 2018, an estimated $9K.
Macquarie Group first reported a position in Imunon in Q4 2017 and held it in 1 quarter.
Macquarie Group's Imunon position peaked at $9K in Q4 2017.
22 funds tracked by Wall St. Rank held Imunon as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.